Vitas CEO Westfall: Market conditions more favorable for hospice acquisitions
03/18/24 at 03:00 AM
Vitas CEO Westfall: Market conditions more favorable for hospice acquisitions
Hospice News, by Jim Parker; 3/15/24
Changes in the marketplace have made further acquisitions by Vitas Healthcare more likely. Vitas, a subsidiary of Chemed Corp. ..., recently announced its first deal in several years, the $85 million purchase of hospice assets from Covenant Health. While the company does not comment on its specific acquisition plans or its pipeline, Vitas may be more active in the M&A space in the coming year, CEO Nick Westfall indicated ...